J Gynecol Oncol.  2016 Jul;27(4):e37. 10.3802/jgo.2016.27.e37.

Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio

Affiliations
  • 1Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy. giorgio.bogani@istitutotumori.mi.it

Abstract

No abstract available.


MeSH Terms

Female
Humans
Leiomyoma/*surgery
*Morcellation/adverse effects
Risk Assessment
United States
United States Food and Drug Administration
Uterine Neoplasms/*surgery
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr